| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |